🇺🇸 Bismuth containing quadruple therapy in United States

Bismuth containing quadruple therapy (Bismuth containing quadruple therapy) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Bismuth containing quadruple therapy in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Bismuth containing quadruple therapy approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Bismuth containing quadruple therapy in United States?

Peking University First Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.